Evidence map›Paper›PMID 41792613›Full record

ArticleBMC microbiology2026

Isolation of Clostridioides difficile from the atmospheric fine particulate matter.

Miyako Ishibashi, Shinya Yonogi, Momoka Tani, Chihiro Hiura, Daisuke Hosokawa, Nami Matsuta, Yusaku Sagisaka, Mayuko Yagi, Tomohiro Hasei, Masahiko Hayashi and 6 more

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Miyako IshibashiDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Shinya YonogiDivision of Microbiology, Osaka Institute of Public Health, 1-3-3, Nakamichi, Higashinari-Ku, Osaka, 537-0025, Japan.
Momoka TaniDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Chihiro HiuraDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Daisuke HosokawaDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Nami MatsutaDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Yusaku SagisakaDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Mayuko YagiDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Tomohiro HaseiPharmaceutical Education Promotion Center, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan.
Masahiko HayashiDepartment of Earth System Science, Faculty of Science, Fukuoka Institute for Atmospheric Environment and Health, Fukuoka University, 8-19-1, Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan.
Yuh ShiwaDepartment of Molecular Microbiology, Faculty of Life Sciences, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.
Fumito MaruyamaCenter for the Planetary Health and Innovation Science (PHIS), The IDEC Institute, Hiroshima University, 1-3-2 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8511, Japan.
Daisuke TanakaGraduate School of Science and Engineering, University of Toyama, 3190 Gofuku, Toyama, Toyama, 930-8555, Japan.
Tomoaki OkudaDepartment of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku, Yokohama, 223-8522, Japan.
Teruya MakiDepartment of Life Science, Faculty of Science and Technology, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka, 577-8502, Japan.
Jun KomanoDepartment of Microbiology and Infection Control, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, 4-20-1 Nasahara, Takatsuki City, Osaka, 569-1041, Japan. jun.komano@ompu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clostridioides difficile is a spore−forming, obligate anaerobic bacillus commonly found in soil and the intestinal tracts of animals. It is a major cause of antibiotic−associated diarrhea (AAD) in humans. Our previous study suggested a possible environmental dissemination. To investigate whether atmospheric aerosols contribute to its spread, atmospheric aerosol samples were collected from ten geographic locations in East Asia, and the presence of C. difficile genomic sequences was assessed using 16S rRNA amplicon sequencing. Additionally, atmospheric PM2.5 samples were collected from two sites in Japan, and analyzed by 16S rRNA amplicon sequencing and selective culturing. C. difficile genomic sequences were detected in aerosols from 8 sampling sites, with relative abundances ranging from 0.03% to 9.88% of total prokaryotic reads. From PM2.5 samples, seven C. difficile strains were isolated, and classified into five genotypes. Three genotypes matched low−frequency clinical or environmental strains in Japan (0.1–0.6%), while two were previously unreported. Phylogenetic analysis showed that four genotypes were closely related to strains from North America, Europe, Africa, and Southeast Asia, respectively. These findings are consistent with the possibility that C. difficile may disperse globally via atmospheric aerosols. Successful colonization of C. difficile in the deposited environments likely depends on ecological adaptability.

Indexed as

Air MicrobiologyClostridioides difficileParticulate MatterAerosolsAsia, EasternDNA, BacterialGenotypeHumansJapanPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNAAerosolsDNA, BacterialParticulate MatterRNA, Ribosomal, 16SAtmospheric aerosolClostridioides difficileGenotypePM2.5

Identifiers

PMID41792613
PMCPMC13078065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.